Ananda Developments Publishes Whitepaper on CBD Clinical Research Ga...

Ananda Developments Plc has released a whitepaper detailing the potential therapeutic benefits and scope of cannabidiol (CBD). The document aims to ad...

Totally Shares Surge 10% After £1M New Business Win

Shares of Totally PLC,(LSE:TLY),surged 10% following the announcement of several new contracts and extensions for its urgent and elective care service...

GSK Optimistic on Zantac Lawsuit and Japan Approvals

On Wednesday, GSK,(LSE:GEK),announced several significant updates. The company welcomed a decision from the Delaware Supreme Court to review a lower c...

Polarean Appoints Xenon MRI Expert as Chief Medical Advisor

Polarean Imaging,(LSE:POLX),has announced the appointment of Dr. Chase Hall as its chief medical advisor. Dr. Hall, renowned for his expertise in pulm...

Diaceutics Reports Advancements in Rare-Disease Offerings

Diaceutics,(LSE:DXRX),announced a major enhancement to its rare-disease offerings on Tuesday, marked by the acquisition of a new contract designed to...

Belluscura Shares Surge on Strong Sales and Improved Outlook

Belluscura,(LSE:BELL),, known for its development of lightweight and portable oxygen enrichment technology, reported significant sales growth and an o...

Faron Pharmaceuticals Gains US Fast-Track Approval for Bexmarilimab

Faron Pharmaceuticals Limited,(LSE:FARN),has received fast-track approval from the US Food and Drug Administration (FDA) for its leading drug candidat...

Shield Therapeutics Shares Rise 7% After Canada Approval

Shares in Shield Therapeutics PLC,(LSE:STX),saw a 7% rise in early trading following the approval of its drug, Accrufer (ferric maltol), by Health Can...

AstraZeneca May Shift UK Vaccine Production to the US

AstraZeneca,(LSE:AZN),has indicated that it might relocate its vaccine manufacturing operations from the UK to the United States if ongoing discussion...

GSK (LSE:GSK) Receives US FDA Breakthrough Therapy Designation for B...

GSK plc (LSE/NYSE:GSK) announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to GSK5764227 (GSK'...

AstraZeneca's Imfinzi Receives New US Approval for Early-Stage Lung...

An prominent player of,Healthcare sector,,AstraZeneca PLC has announced that its immunotherapy drug Imfinzi (durvalumab) has been granted an additiona...

IXICO Expects Positive Performance in FY24 with New Contract Wins Bo...

IXICO plc (LSE:IXI), a leading medical imaging and advanced analytics company focused on neuroscience, has issued a promising trading update for the f...

AstraZeneca Becomes First UK-Listed Firm to Hit £200 Billion

AstraZeneca PLC (,LSE:AZN,) has made history as the first company listed on the London Stock Exchange to reach a market valuation exceeding £200 billi...

IQ-AI Moves Closer to FDA Review with Phase 1 Trial Wrap-Up

IQ-AI Ltd has announced that its Phase 1 clinical trial for IB003, a gallium maltolate treatment for children's brain cancer, is nearing completion. T...

Celadon Pharmaceuticals Shares Fall as Funding Delays Impact Financi...

Celadon Pharmaceuticals PLC (LSE: CEL) announced on Monday that it is still awaiting essential cash inflows, though its operations remain aligned with...

Bivictrix Therapeutics Plans AIM Delisting to Advance Pipeline as Pr...

Bivictrix Therapeutics PLC (LSE: BVX) announced on Monday its decision to delist from AIM in order to seek funding as a private company to advance its...

New Research Partnership Aims to Advance Corneal Treatment

BSF Enterprise PLC (LSE: BSFA), a biotech company listed on the Main Market and owner of Kerato Ltd, has announced a research partnership with the Uni...

Genedrive Secures Initial Order for CYP2C19-ID Test Following NICE E...

Genedrive plc (LSE:GDR), a leader in point-of-care pharmacogenetic testing, has announced the receipt of an initial order for its CYP2C19-ID Kit and a...

Celadon Pharmaceuticals Highlights Recent Progress and Financial Pos...

Celadon Pharmaceuticals Plc (LSE: CEL), a UK-based pharmaceutical firm specializing in cannabis-based medicines, reports that its operations are proce...

Hikma Pharmaceuticals Surpasses Expectations with Earnings Report

Hikma Pharmaceuticals PLC, a key player in the,healthcare sector,, recently released its half-yearly financial results, which exceeded market expectat...